Card MTS GEL TST anti a B D mncln rvrs

Ended Awarded Last action

Contract number
W81K0220F0162
Awardee
Awarding agency
Obligated
$153,336

Award facts

Contract value 100% obligated
$153,335.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Other Administrative Action P00012 · Microbiology ID cards and anitimicrobial susceptibility testing analyzer/reagents $0
Funding Only Action P00011 · Card MTS GEL TST anti a B D mncln rvrs MOD P00011 release FY25 funds $30,778
Exercise an Option P00010 · Exercise option 4 - 10/01/2024-09/30/2025 $0
Funding Only Action P00009 · Card MTS GEL TST anti a B D mncln rvrs: MOD P00009 release FY24 funds $30,778
Exercise an Option P00008 · Card MTS GEL TST anti a B D mncln rvrs MOD P00008 exercise option III 10/01/2023-09/30/2024 $0
Funding Only Action P00007 · Modification - funding option (2) - card MTS GEL TST anti a B D mncln rvrs $30,778
Exercise an Option P00006 · Modification to exercise option (2) - card MTS GEL TST anti a B D mncln rvrs $0
Supplemental Agreement for work within scope P00005 · Modification base YR DE-obligation - card MTS GEL TST anti a B D mncln rvrs -$554
Funding Only Action P00004 · Modification funding option (1) - card MTS GEL TST anti a B D mncln rvrs $30,778
Exercise an Option P00003 · Modification to exercise option (1) - card MTS GEL TST anti a B D mncln rvrs $0
Funding Only Action P00002 $30,778
Supplemental Agreement for work within scope P00001 · Modification to add far 889 language - card MTS GEL TST anti a B D mncln rvrs $0
Original award $0
Show all 15

About this award

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on October 1, 2020, with a ceiling value of $153,335.80 under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule for microbiology identification cards and antimicrobial susceptibility testing analyzer and reagents. Place of performance is Raritan, NJ. The order ultimate completion date is September 30, 2025. Pricing is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract W81K0220F0162?

W81K0220F0162 was awarded to Quidelortho Sales Company, LLC by Defense Health Agency (Department of Defense) on October 1, 2020.

How much is contract W81K0220F0162 worth?

The government has obligated $153,336 on W81K0220F0162.

Is contract W81K0220F0162 an order under another contract?

Yes. W81K0220F0162 is a delivery order under V797D60637, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract W81K0220F0162 competed?

The extent of competition for W81K0220F0162 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award